Sunil Babu

1 ta ish

AbbVie (United States)

1. Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidine

   Hartmut Döhner, Keith W. Pratz, Courtney D. DiNardo +15

   MaqolaOAOchiq kirish20242 iqtibos

   ABIABI:AkademIndex/2026.other.244235